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Abstract
We developed a non-invasive method to measure and quantify human circadian PER2 gene expression in oral mucosa samples and
show that this gene oscillates in a circadian (¼ about a day) fashion. We also have the ﬁrst evidence that induction of human PER2
expression is stimulated by exposing subjects to 2 h of light in the evening. This increase inPER2 expressionwas statistically signiﬁcant
in comparison to a non-light control condition only after light at 460 nm (blue) but not after light exposure at 550 nm (green). Our results
indicate that the non-image-forming visual system is involved in human circadian gene expression. The demonstration of a functional
circadianmachinery in humanbuccal samplesand its response to light opens thedoor for investigationof humancircadian rhythmsat the
gene level and their associated disorders.
Introduction
Our light-sensing systems’ familiar function is to collect and process
light to generate an image of the world. Although light primarily serves
vision, it is now known that it also exerts powerful non-visual effects on
a number of physiological variables in humans, among them synchron-
ization of circadian rhythms (the circa-24-h rhythms) (Lockley et al.,
2003; Warman et al., 2003), suppression of the hormone melatonin
(Brainard et al., 2001a,b; Thapan et al., 2001; Lockley et al., 2003;
Cajochen et al., 2005), an increase in cortisol and heart rate (Scheer &
Buijs, 1999; Scheer et al., 1999; Cajochen et al., 2005), and an acute
alerting response (Badia et al., 1991; Cajochen et al., 2005). In
mammals, light activates signalling pathways in a brain regionwhere the
central circadian pacemaker is located ) the suprachiasmatic nuclei
(SCN) (Klein et al., 1991) ) that coordinates the daily temporal
organization of physiology and behaviour. The molecular mechanisms
underlying circadian rhythmicity involve self-sustaining transcrip-
tional ⁄ translational feedback loops based on rhythmic expression of
the mRNA and proteins of clock components. Synchronization of the
SCN to light ultimately leads to expression of a set of clock genes,
among them Per1 and Per2 (Albrecht et al., 1997). Thus, light exposure
acutely activates expression of Per1 and Per2 in the SCN of mice
(Albrecht et al., 1997; Zylka et al., 1998; Yan et al., 1999).
Reports about circadian regulation of clock genes in humans are
rare. Two recent studies provide evidence that clock genes (PER1,
PER2, PER3 and DEC1) in human peripheral blood mononuclear cells
(Boivin et al., 2003) and human oral mucosa (PER1, CRY1 and
BMAL1) are expressed in a circadian manner (Bjarnason et al., 2001).
In the present study we aimed at developing a method to measure
circadian expression of PER2 expression in a non-invasive way via
collection of oral mucosa samples. In a second step, we tested the
hypothesis that evening light exposure induces an immediate increase
in PER2 expression in human mucosa. Furthermore, because part of
light’s non-visual effects are mediated by non-classical photoreceptors
with melanopsin acting as photopigment with a maximum sensitivity
in the ‘blue’ part of the visible electromagnetic spectrum (Lucas et al.,
1999; Melyan et al., 2005; Panda et al., 2005; Qiu et al., 2005), we
applied light in the 460 nm range and compared its effect to light at a
different wavelength (550 nm) to test to what extend the novel
photoreceptor system is involved in the regulation of PER2.
Materials and methods
Study participants
Twelve male volunteers were studied in the light study (mean age ±
SD, 25.3 ± 3.6 years), and 12 female and male volunteers in the
circadian study (28.4 ± 9.9 years). All study participants were free
from medical, psychiatric and sleep disorders, as assessed by history, a
physical examination and questionnaires. For the participants in the
light study an ophthalmological examination was carried out prior to
and after completion of the study in order to exclude volunteers with
visual impairments as well as to be certain that our light application
was not harmful. The volunteers were instructed to abstain from
excessive caffeine and alcohol consumption for 1 week before the
study. They were asked to keep a regular sleep–wake schedule
(bedtimes and waketimes within ± 30 min of self-selected target time)
during 1 week prior to their admission to the laboratory. Adherence to
this regular schedule was veriﬁed with a wrist actigraph (Cambridge
Neurotechnologies, UK) and daily sleep diaries for the participants in
the light study. All volunteers gave written informed consent. The
protocol, screening questionnaires and consent form were approved by
the Ethical Committee of Basel, Switzerland, and were in agreement
with the Declaration of Helsinki.
Study protocol
Light study
The study consisted of three arms, performed in a balanced order,
separated by a 1-week intervening period (Fig. 1). Based on the
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volunteers’ habitual bedtimes, a constant posture (CP) protocol started
10 h after usual waketime in the early evening (e.g. 18.00 h) and ended
the next day, 2 h after usual waketime (e.g. 10.00 h). Under CP
conditions, the volunteers experienced a controlled lying down episode
of 1.5 h under 2 lux, followed by a 2-h dark adaptation episode under
complete darkness (0 lux). After that, light exposurewas initiated for the
next 2 h. During this 2-h episode, the volunteers received monochro-
matic light at 460 nm, or monochromatic light at 550 nm, or no-light
(0 lux). After this, the volunteers remained awake for another 1.5-h
episode under 2 lux (polychromatic white light) before they were
allowed to sleep for 7.75 h. One study participant developed amild cold
during one of the study arms and was therefore excluded from further
analysis. To quantify PER2 expression, oral mucosa samples were
collected at 18.30 h before light exposure, at 24.00 h after light exposure
and the next morning at 10.00 h. For two study participants not enough
mucosa material was available for a reliable quantiﬁcation of PER2,
resulting in a total of nine subjects for statistical analysis.
Circadian study
The study comprised a 30-h episode, which the volunteers spent in
one of our temperature-controlled chronobiology suites. The
volunteers were allowed to read, work on a laptop and listen to
music. Ambient light levels were kept low, < 15 lux at the angle of
gaze, and meals were provided by the clinic (lunch, dinner and
breakfast). An 8-h sleep episode was scheduled according to the
volunteers’ habitual bedtime. The mucosa and the saliva samples
for melatonin were taken in 3-hourly intervals, starting 3 h after
habitual bedtime (on average at 9.00, 12.00, 15.00, 18.00, 21.00,
24.00, 3.00, 6.00, 9.00, 12.00 h). For double-plotting, the last two
data points at 9.00 and 12.00 h were omitted. In order to take the
3.00 and 6.00 h samples, volunteers had to wake up, take the
sample and go back to sleep. One subject discontinued the study
after 12 h because of difﬁculties in taking mucosa samples, and two
subjects had to be excluded because not enough mucosa material
was available for a reliable quantiﬁcation of PER2. The circadian
study was conducted 3 months after the light study was completed.
Because the experimental conditions of the subjects in the two
studies were different it is not possible to compare the PER2 data
of the two studies in their absolute dimension, as the Q-PCR
method used was based on relative measures in each experiment.
Light exposure
Monochromatic 2-h light exposure was scheduled at a circadian phase at
which polychromatic white light exposure induces robust phase delays
and alerting effects (Cajochen et al., 1992, 1998; Khalsa et al., 2003).
The monochromatic light was generated by a 300 Watt arc-ozone-free
Xenon lamp (Thermo Oriel, Spectra Physics, Statford, CT, USA),
ﬁltered by either 460 nm or 550 nm (Interference ﬁlter, ± 10 nm half-
peak bandwidth, Spectra Physics, Statford, CT, USA) and transmitted
via two glass ﬁbre bundles (L.O.T. Oriel-Suisse, Romanel-sur-Morges,
Switzerland) through the wall into the sound-proof and temperature-
controlled chronobiology suite on to the goggles, which covered the
volunteers’ eyes. The custom-built goggles (K. Haug AG, Basel,
Switzerland) consisted of two spheres (27.5 mm inner radius) coated
with white reﬂectance paint (two component polyurethan-acryl anti-
fading paint, Lachenmeier & Co. AG, Basel, Switzerland). Each sphere
was illuminated via three branches of the main ﬁbre optic cable in order
to provide constant uniform illumination. Equal photon densities
(2.8 · 1013 photons ⁄ cm2 ⁄ s) for the 460 nm and 550 nm wavelength
light were administered. This irradiance level (12.1 lW ⁄ cm2 for
460 nm and 10.05 lW ⁄ cm2 for 550 nm) was chosen according to
recently reported results onmonochromatic light on the human circadian
timing system (Lockley et al., 2003). Irradiances were measured with a
laser power meter (Laser Check, Coherent, Auburn, CA, USA) before
the beginning and at the end of each light exposure. During light
exposure as well as during the non-light condition, volunteers were
asked to keep their eyes open and to ﬁx their gaze on the middle of the
spheres. A technician checked the latter by on-line monitoring the
polysomnographic recordings and also verifying that the subjects
remained awake. The volunteer’s pupils were not dilated in order to
avoid possible repercussions of the dilation agent per se on thermoreg-
ulation, heart rate and alertness. However, we tested the effects of the
light stimulus on pupil constriction by applying monocular light
exposure (light via the goggle of the right eye) and concomitantly
measuring the pupil size on the left eye via an infrared camera. The entire
control protocol was conducted at the same time of day (evening) and
with the same light intensity in six subjects. Results from the control
experiment revealed a signiﬁcantly smaller pupil size after the short
wavelength light at 460 nm than after light at 550 nm in comparison to
the dark condition (P < 0.01), Duncan’s multiple range test performed
after a one-way anova for repeated measures with the factor ‘light
condition’ (P < 0.02; dark, 460 nm and 550 nm).
Salivary melatonin
Saliva was collected at 30-min intervals during scheduled wakeful-
ness. A direct double-antibody radioimmunoassay was used for the
melatonin assay validated by gas-chromatography-mass spectroscopy
(Bu¨hlmann Laboratories, Allschwil, Switzerland). The minimum
detectable dose of melatonin (analytical sensitivity) was determined
to be 0.2 pg ⁄mL. The functional least detectable dose using the < 20%
coefﬁcient of interassay variation criterion was below 0.65 pg ⁄mL,
and individual serum and saliva melatonin proﬁles showed excellent
parallelism (r ¼ 0.977–0.999, slopes ¼ 0.21–0.63).
Human oral mucosa collection and quantiﬁcation of PER2
Human oral mucosa was collected using blue pipette tips (Treff AG,
2 mm of tissue into the tip) and then was dissolved in lysis buffer
containing b-mercaptoethanol provided in the Absolutely RNA Nano-
prepKit (Stratagene). Subsequently, the samples were frozen at)80 C.
The RNAwas isolated according to the manufacturer’s instructions of
the kit using 200 lL of lysis buffer followed by a DNase treatment of
30 min. The cDNA was generated using SuperScriptTM II Reverse
Transcriptase (Invitrogen) and poly(dT)15 primers (Roche). Subse-
quently, TaqMan quantitative real-time RT-PCR was performed using
iQ Supermix (Bio-Rad) to determineGAPDH and PER2 levels for each
sample. The following primers and probes were used:
PER2 TaqMan probe:
5¢-[FAM]ATGCCTTCAGCGATGCCAAGTT[BHQ]-3¢
PER2 sense primer:
5¢-GCATCCATATTTCACTGTAAAAGA-3¢
PER2 anti-sense primer:
5¢-AGTAAAAGAATCTGCTCCACTG-3¢
GAPDH TaqMan probe:
5¢-[FAM]AGCCTCAAGATCATCAGCAATGCC [BHQ]-3¢
GAPDH sense primer:
5¢-TGTGAACCATGAGAAGTATGAC-3¢
GAPDH anti-sense primer:
5¢-ATGAGTCCTTCCACGATACC-3¢.
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The ﬁnal primer concentration was 300 nm, ﬂuorescent oligomeric
probe concentration was 100 nm and MgCl2 concentration was 5 mm.
The ampliﬁcation was carried out at 55 C for 1 min followed by a
denaturation at 94 C for 15 s using the iCycler (Bio-Rad). After 55
cycles, DCT was determined. The samples of one subject (all time
points) in the reaction mix were applied with ﬁlter tips (Axigen) onto a
0.2 mL semiskirted thermo-fast 96-well plate (ABgene AB-0900),
which was covered with an optically clear adhesive seal sheet
(ABgene AB-1170). Additionally to the single GAPDH controls, a
dilution curve for GAPDH was run on each plate for one time point to
control for reaction efﬁciency.
GAPDH was used as standard because of its constant expression in
mucosa tissue (Pan et al., 2002) and its validation as a standard gene for
this tissue under injury and repair conditions (Warburton et al., 2005).
Data analysis
For both the circadian and the light study three reference GAPDH
values and three or four PER2 values were obtained for each mucosa
sample (triplets or quadruplets a, b, c, d). A DCT value per mucosa
sample was calculated according to the comparative CT (2
–DDCT)
method, which could be applied because the efﬁciencies of the
GAPDH and PER2 assays were optimized to be comparable (Livak &
Schmittgen, 2001). A validation assay was performed where serial
dilutions were assayed for both genes. This method minimizes the
variation in performance of the iCycler apparatus. Another advantage
of this relative quantiﬁcation compared with the absolute method is
that it corrects for variance in the efﬁciency of cDNA synthesis.
The formula below was used to calculate the DCT values:
DCT ¼ ð2GAPDHaPER2a þ 2GAPDHaPER2b þ 2GAPDHaPER2c
þ 2GAPDHbPER2a þ 2GAPDHbPER2b þ 2GAPDHbPER2c
þ 2GAPDHcPER2a þ 2GAPDHcPER2b þ 2GAPDHcPER2cÞ=9
In the case of quadruplets, the formula was changed accordingly. This
method allowed the use of parametric statistics repeated-measure
anova (ranova) with the factor ‘light condition’ and ‘time of day’.
Fig. 1. Overview of the light study protocol design. After 1.5 h under 2 lux, subjects were dark adapted for 2 h, followed by another 2 h in darkness or light
exposure at 460 nm or 550 nm (for details about the light exposures, see Materials and methods). Subsequently, subjects spent 1.5 h under 2 lux before they were
allowed to sleep for 8 h. The entire protocol was carried out under constant recumbent posture conditions in bed.
Fig. 2. (a) Twenty-four-hour proﬁle of PER2 expression in human oral mucosa (d) and of salivary melatonin levels (s). Samples were taken in 3-h intervals under
dim light conditions (< 15 lux) throughout a 30-h period (n ¼ 9, mean values ± SEM). For better visualization of the 24-h rhythms, all values were double-plotted
and PER2 values ﬁtted with a sine function. The r-value, an estimate of the goodness of ﬁt, was 0.87 with P ¼ 0.0001 for PER2. Arrows on the abscissa indicate the
timing of mucosa collection and the timing of the 2-h light exposure (yellow bar) in the experiment in (b). (b) Left-hand side: Salivary melatonin levels during 2-h
light exposure at 460 nm and 550 nm and during the control no-light condition. Right hand side: PER2 expression in oral mucosa after the 2-h light exposure (460
and 550 nm) and no-light exposure at 24.00 h and 10.00 h the next morning. Values were expressed as percentages to the value before light treatment at 18.30 h
(0 ¼ value at 18.30 h; n ¼ 9, mean values + SEM; *P < 0.05, Duncan’s multiple range test). (c) Scatter plot of the individual normalized data. After blue light at
460 nm, for most of the subjects values > 1.0 can be observed at 24 h, but also for some subjects after green light at 550 nm and for two subjects in the dark
condition. Only in the blue light condition did the values at 24.00 h differ signiﬁcantly from the 18.30 h values (paired t-test, P ¼ 0.017). For most of the subjects in
the blue light condition, the values at 10.00 h the next morning decreased, statistical analyses revealed a trend for lower values after blue light, when compared with
the green condition (paired t-test; P ¼ 0.09).
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For each subject, we expressed the transformed values relative to the
value obtained at 18.00 h in the circadian study and to the value
obtained at 18.30 h in the light study, as in the light study the sample
taken at 18.30 h was the only sample taken under the same lighting
conditions and was the closest in terms of time to the 18.00 h sample
taken in the circadian study. All P-values derived from ranovas were
based on Huynh–Feldt’s (H–F) corrected degrees of freedom, but the
original degrees of freedom are reported. For post-hoc comparisons
the Duncan’s multiple range test was used.
The time course of PER2 expression in the circadian study was
ﬁtted with a sinusoidal function comprising the fundamental oscilla-
tion (24-h component):
f ðtÞ ¼ y0 þ A sin½ð2pt=s24Þ þ c:
Data were ﬁt with a non-linear least-square ﬁtting analysis based upon
the Marquardt–Levenberg algorithm to ﬁnd the coefﬁcients (param-
eters) of the independent variable(s) that give the best ﬁt between the
equation and the data (SigmaPlot for Windows, Version 7.0,
Richmond, CA, USA, Systat Software). The goodness-of-ﬁt of each
sine ﬁt was assessed by calculating the adjusted correlation coefﬁcient
and the power, or the probability that the model correctly describes the
relationship of the variables, if there is a relationship. The statistical
package Statistica (StatSoft 2004, Statistica for Windows, Tulsa, OK,
USA, Version 6.0) was used.
Results
PER2 gene expression in the circadian study showed a clear diurnal
rhythm (Fig. 2a). The sine ﬁt to the data points yielded a good ﬁt with
a r-value of 0.87, and the power that the model correctly describes the
relationship between the variables was 0.99. Maximal PER2 gene
expression in oral mucosa, sampled in 3-h intervals throughout a 30-h
period under controlled dim lighting conditions, occurred between
12.00 and 15.00 h during the biological day, while minimal PER2
expression was found between 21.00 and 03.00 h during the
biological night, deﬁned as the period of melatonin secretion. The
circadian proﬁle of the salivary melatonin exhibited the well-known
time course (Fig. 2a), with maximal values during night-time hours
and low values during daytime. The phase and amplitude of the
melatonin curve was very similar to the one we have recently reported
(Knoblauch et al., 2003).
Figure 2b illustrates changes in PER2 expression and salivary
melatonin in the light study. A ranova with the factor ‘light
condition’ and ‘time of day’ yielded a signiﬁcant effect of ‘time of
day’ (F1,8 ¼ 8.4, P ¼ 0.020) and a signiﬁcant interaction between
‘light condition’ and ‘time of day’ (F2,16 ¼ 4.6, P ¼ 0.027). Post-hoc
comparisons revealed a signiﬁcant increase in PER2 expression after
blue light at 460 nm at 24.00 h (P ¼ 0.032), but not after green light
at 550 nm (P ¼ 0.28). The comparison between blue and green light
at this time point (24.00 h) did not reach signiﬁcance (P ¼ 0.18).
Melatonin was signiﬁcantly suppressed after blue light at 460 nm
(from 12.0 pg ⁄mL to 8.8 pg ⁄mL, P ¼ 0.021), but not after green
light at 550 nm. At this time point PER2 levels are usually near
minimal levels (Fig. 2a).
PER2 gene expression the next morning at 10.00 h no longer
differed signiﬁcantly, nor did melatonin levels. Nonetheless, a
tendency for a lower PER2 gene expression was found after blue light
at 460 nm when compared with green light at 550 nm (P ¼ 0.098).
In the scatter plot showing individual data (Fig. 2c), for most of the
subjects values > 1.0 can be observed at 24 h after blue light, but also
for some subjects after green light and for two subjects in the dark
condition. However, only in the blue light condition did the values at
24.00 h differ signiﬁcantly from the 18.30 h values (paired t-test
P ¼ 0.017). For most of the subjects in the blue light condition, the
values at 10.00 h the next morning decreased and a trend for lower
values after blue light when compared with the green light was found
(see paragraph above).
Discussion
We were able to show rhythmic expression of a clock gene PER2 in
peripheral human tissue collected non-invasively from the oral
mucosa. In addition, our ﬁndings provide the ﬁrst evidence in humans
that a circadian regulator gene, PER2, acutely responds to light.
Importantly, this response to light was clearly wavelength-dependent,
such that the increase in PER2 after light is blue-shifted relative to the
three-cone visual photopic system, supporting a role of the novel ‘non-
photic’ photoreceptors at the level of human clock gene expression.
Circadian expression of PER2 in our study peaked on average 12 h
later, during the biological day at 15.00 h, with respect to maximal
melatonin expression at 03.00 h. Although a bit later into the day, it is
in accordance with Boivin et al. (2003), who reported peak PER2
expression mostly during the habitual time of activity (around noon) in
human peripheral blood mononuclear cells.
We have evidence that the induction of PER2 is acutely
stimulated by evening light exposure in the human mucosa. Studies
in rats show that the clock of peripheral tissues, such as liver and
kidney, takes more time to adjust its phase to a shifted light–dark
cycle compared with the SCN (Yamazaki et al., 2000). In contrast,
our study indicates that oral mucosa might be a tissue that responds
rather quickly to such changes as shown by the rapid response of
the PER2 gene to light in this tissue. Whether this represents an
acute stimulation of PER2 in the central circadian clock in the SCN
can not be conclusively proven in this study. However, the light-
evoked reduction of melatonin and increase in core body tempera-
ture and heart rate published in the same subject sample (Cajochen
et al., 2005) are clear indications for non-visual circadian effects of
light, which are mediated by the SCN. Therefore, we assume that
the light effects reported here on PER2 were most likely mediated
via the circadian system. Further support for this comes from the
fact that only the short-wavelength light (i.e. blue light) evoked this
effect. It is known that the human circadian system is particularly
sensitive to non-visual effects of ocular light at short wavelengths
via novel photoreceptors (Provencio et al., 2000; Hankins & Lucas,
2002; Hattar et al., 2002; Gooley et al., 2003).
The demonstration of a functional circadian machinery in human
buccal samples and its response to the most important Zeitgeber light
suggests that this method may be useful for the investigation of human
circadian rhythms at the gene level and their associated disorders.
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